Skip to main content

ADx NeuroSciences

Always up-to-date of the latest developments

28 February 2024

ADx will attend AD/PD 2024

ADx is excited to attend AD/PD 2024 this year in…
31 January 2024

Scientific articles in 2024

In 2024, ADx remains committed to fostering collaborative efforts with…
4 December 2023

We officially moved into our new offices!

More than a year ago our company was welcomed into…
26 October 2023

ADx will attend CTAD 2023

ADx is excited to attend CTAD 2023. Keep an eye…
10 July 2023

ADx will attend AAIC2023

ADx is excited to attend AAIC2023 this year in Amsterdam,…
15 March 2023

ADx is attending CSF society 2024

Come and meet us at the CSF Society Conference in…
31 January 2023

Scientific articles in 2023

In 2023 ADx will continue to collaborate with its research…
31 January 2023

ADx will attend the clinical workshop CURE-ND in Paris

On friday February 3rd, ADx NeuroSciences will attend a workshop…
23 June 2022

Fujirebio acquires ADx NeuroSciences and confirms its intentions to bring better and earlier neurodegenerative disease diagnostic solutions to the global diagnostics industry

Gent, Belgium and Tokyo, Japan, June 23, 2022 – H.U.…
28 January 2022

Scientific articles in 2022

In 2022 ADx will continue to collaborate with its research…
19 January 2022

ADx NeuroSciences’ review of 2021

2021 was a remarkable year for ADx. Check out our…
18 January 2022

Scientific articles in 2021

In 2021, ADx NeuroSciences' collaborators worked intensively on groundbreaking scientific…
31 December 2020

Scientific articles in 2020

In 2020, ADx NeuroSciences' collaborators have been intensively participating in…
1 July 2020

ADx will be present at the upcoming virtual AAIC 2020

Discover the new findings in blood and synaptic biomarkers at…
9 April 2020

Cancellation ADx Neuro Biomarker Conference

We regret to announce that the ADx Neuro Biomarker Conference…
2 April 2020

ADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state.

While the classical fluid markers, tau and amyloid, accord well…
31 December 2019

Scientific articles in 2019

In 2019, ADx NeuroSciences' collaborators were intensively participating in groundbreaking…
11 December 2019

Present at CTAD 2019

ADx NeuroSciences will be present at CTAD. You can reach…
10 December 2019

ADx receives funding from Bill Gates for developing blood biomarkers

Together with Douglas Galasko, M.D. University of California at San…
31 December 2018

Scientific articles in 2018

ADx NeuroSciences is an R&D company and its people are…